Impact of Left Ventricular Ejection Fraction on Clinical Outcomes Over Five Years After Infarct-Related Coronary Artery Recanalization (from the Occluded Artery Trial [OAT])

American Journal of Cardiology

Volumn 105, Issue 1, 2010, Pages 10-16

  Kruk, Mariusz ^a   Buller, Christopher E ^b   Tcheng, James Enlou ^c   Dzavík, Vladimir ^d   Menon, Venugopal ^e   Mancini, G B John ^b   Forman, Sandra A ^f   Kurray, Peter ^g   Busz Papiez, Benita ^h   Lamas, Gervasio A ⁱ   Hochman, Judith S ^j  

^a INSTITUTE OF CARDIOLOGY   (Poland)

^b VANCOUVER GENERAL HOSPITAL   (Canada)

^c DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^d UNIVERSITY HEALTH NETWORK   (Canada)

^e LERNER RESEARCH INSTITUTE   (United States)

^f MARYLAND MEDICAL RESEARCH INSTITUTE   (United States)

^g NATIONAL INSTITUTE OF CARDIOVASCULAR DISEASES   (Slovakia)

^h Wojewodzki Szpital Zespolony   (Poland)

ⁱ MOUNT SINAI MEDICAL CENTER   (United States)

^j NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; THIENOPYRIDINE DERIVATIVE;

ACUTE HEART INFARCTION; ADULT; ARTERY OCCLUSION; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY RECANALIZATION; FEMALE; HEART DEATH; HEART LEFT VENTRICLE CONTRACTILITY; HEART LEFT VENTRICLE EJECTION FRACTION; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; TREATMENT OUTCOME;

ECHOCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; GATED BLOOD-POOL IMAGING; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REVASCULARIZATION; PROGNOSIS; RETROSPECTIVE STUDIES; STROKE VOLUME; TIME FACTORS; VENTRICULAR FUNCTION, LEFT;

EID: 72049090908     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2009.08.644     Document Type: Article

References (26)

1. White H.D., Norris R.M., Brown M.A., Brandt P.W., Whitlock R.M., and Wild C.J. Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation 76 (1987) 44-51
2. Coronary artery surgery study (CASS): a randomized trial of coronary artery bypass surgery. Survival data. Circulation 68 (1983) 939-950
3. Chareonthaitawee P., Gersh B.J., Araoz P.A., and Gibbons R.J. Revascularization in severe left ventricular dysfunction: the role of viability testing. J Am Coll Cardiol 46 (2005) 567-574
4. Hochman J.S., Lamas G.A., Buller C.E., Dzavik V., Reynolds H.R., Abramsky S.J., Forman S., Ruzyllo W., Maggioni A.P., White H., Sadowski Z., Carvalho A.C., Rankin J.M., Renkin J.P., Steg P.G., Mascette A.M., Sopko G., Pfisterer M.E., Leor J., Fridrich V., Mark D.B., and Knatterud G.L. Coronary intervention for persistent occlusion after myocardial infarction. N Engl J Med 355 (2006) 2395-2407
5. Dzavik V., Buller C.E., Lamas G.A., Rankin J.M., Mancini G.B., Cantor W.J., Carere R.J., Ross J.R., Atchison D., Forman S., Thomas B., Buszman P., Vozzi C., Glanz A., Cohen E.A., Meciar P., Devlin G., Mascette A., Sopko G., Knatterud G.L., Hochman J.S., and TOSCA-2 Investigators. Randomized trial of percutaneous coronary intervention for subacute infarct-related coronary artery occlusion to achieve long-term patency and improve ventricular function: the Total Occlusion Study of Canada (TOSCA)-2 trial. Circulation 114 23 (2006) 2449-2457
6. Hochman J.S., Lamas G.A., Knatterud G.L., Buller C.E., Džavík V., Mark D.B., Reynolds H.R., White H.D., and Occluded Artery Trial Research Group. Design and methodology of the Occluded Artery Trial (OAT). Am Heart J 150 (2005) 627-642
7. Konstam M.A., Dracup K., Bottorff M.B., Brooks N.H., Dacey R.A., Dunbar S.B., Jackson A.B., Jessup M., Johnson J.C., Jones R.H., Luchi R.J., Massie B.M., Pitt B., Rose E.A., Rubin L.J., and Wright R.F. Heart failure: management of patients with left-ventricular systolic dysfunction. National Library of Medicine DOCLINE information: MED/94282113 (1994)
8. Kruk M., Kadziela J., Sadowski Z.P., Barton B.A., Mark D.B., Forman S.A., Reynolds H.R., Maggioni A.P., Leor J., Webb J.G., Kapeliovich M., Marin-Neto J.A., White H.D., Lamas G.A., and Hochman J.S. Predictors of outcome and the lack of effect of PCI across the risk strata in patients with persistent total occlusion after myocardial infarction: results from the Occluded Artery Trial (OAT). JACC Cardiovasc Interv 1 (2008) 511-520
9. Udelson J.E., Pearte C.A., Kimmelstiel C.D., Kruk M., Teresinska A., Bychowiec B., Marin-Neto J.A., Preto R., Hochtl T., Cohen E.A., Caramori P., Busz-Papiez B., AdIbrecht C., Sadowski Z.P., Ruzyllo W., Forman S.A., Kinan D.J., Lamas G.A., and Hochman J.S. The occluded artery trial (OAT) viability ancillary study (OAT-NUC): influence of infarct zone viability on left ventricular remodeling after PCI vs. medical therapy alone. Circulation 116 (2007) 624-625
10. Moussa I., Di Mario C., Reimers B., Akiyama T., Tobis J., and Colombo A. Subacute stent thrombosis in the era of intravascular ultrasound-guided coronary stenting without anticoagulation: frequency, predictors and clinical outcome. J Am Coll Cardiol 29 (1997) 6-12
11. Bounous E.P., Mark D.B., Pollock B.G., Hlatky M.A., Harrell Jr. F.E., Lee K.L., Rankin J.S., Wechsler A.S., Pryor D.B., and Califf R.M. Surgical survival benefits for coronary disease patients with left ventricular dysfunction. Circulation 78 (1988) I151-I157
12. Allman K.C., Shaw L.J., Hachamovitch R., and Udelson J.E. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol 39 (2002) 1151-1158
13. Velazquez E.J., Lee K.L., O'Connor C.M., Oh J.K., Bonow R.O., Pohost G.M., Feldman A.M., Mark D.B., Panza J.A., Sopko G., Rouleau J.L., and Jones R.H. The rationale and design of the Surgical Treatment for Ischemic Heart Failure (STICH) trial. J Thorac Cardiovasc Surg 134 (2007) 1540-1547
14. Shah P.K. Distal embolization after percutaneous coronary interventions: prediction, prevention, and relevance. J Am Coll Cardiol 50 (2007) 1647-1648
15. Jorapur V., Steigen T.K., Buller C.E., Dzavik V., Webb J.G., Strauss B.H., Yeoh E.E.S., Kurray P., Sokalski L., Machado M.C., Kronsberg S.S., Lamas G.A., and Hochman J.S. Distribution and determinants of myocardial perfusion grade following late mechanical recanalization of occluded infarct-related arteries post-myocardial infarction: A report form the occluded artery trial. Catheter Cardiovasc Interv 72 (2008) 783-789
16. Malek L.A., Reynolds H.R., Vozzi C., Dziarmaga M., French J.K., Mancini G.B., Forman S., Renkin J.P., Lamas G.A., and Hochman J.S. Late coronary intervention in stable patients after myocardial infarction for totally occluded LADs does not reduce events compared to medical therapy alone: results from the Occluded Artery Trial (OAT). Eur Heart J 29 Abstract Suppl (2008) 514-515
17. Rutherford J.D., Pfeffer M.A., Moye L.A., Davis B.R., Flaker G.C., Kowey P.R., Lamas G.A., Miller H.S., Packer M., Rouleau J.L., Braunwald E., and SAVE Investigators. Effects of captopril on ischemic events after myocardial infarction. Results of the Survival and Ventricular Enlargement trial. Circulation 90 (1994) 1731-1738
18. The CONSENSUS Trial Study Groupt. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 316 (1987) 1429-1435
19. Goldstein S., and Hjalmarson A. The mortality effect of metoprolol CR/XL in patients with heart failure: results of the MERIT-HF Trial. Clin Cardiol 22 Suppl 5 (1999) V30
20. Dargie H.J. Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial. Lancet 357 (2001) 1385-1390
21. Boden W.E., O'Rourke R.A., Teo K.K., Hartigan P.M., Maron D.J., Kostuk W.J., Knudtson M., Dada M., Casperson P., Harris C.L., Chaitman B.R., Shaw L., Gosselin G., Nawaz S., Title L.M., Gau G., Blaustein A.S., Booth D.C., Bates E.R., Spertus J.A., Berman D.S., Mancini G.B., and Weintraub W.S. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 356 (2007) 1503-1516
22. Erne P., Schoenenberger A.W., Burckhardt D., Zuber M., Kiowski W., Buser P.T., Dubach P., Resink T.J., and Pfisterer M. Effects of percutaneous coronary interventions in silent ischemia after myocardial infarction: the SWISSI II randomized controlled trial. JAMA 297 (2007) 1985-1991
23. Horie H., Takahashi M., Minai K., Izumi M., Takaoka A., Nozawa M., Yokohama H., Fujita T., Sakamoto T., Kito O., Okamura H., and Kinoshita M. Long-term beneficial effect of late reperfusion for acute anterior myocardial infarction with percutaneous transluminal coronary angioplasty. Circulation 98 (1998) 2377-2382
24. Steg P.G., Thuaire C., Himbert D., Carrie D., Champagne S., Coisne D., Khalife K., Cazaux P., Logeart D., Slama M., Spaulding C., Cohen A., Tirouvanziam A., Montely J.M., Rodriguez R.M., Garbarz E., Wijns W., Durand-Zaleski I., Porcher R., Brucker L., Chevret S., and Chastang C. DECOPI (DEsobstruction COronaire en Post-Infarctus): a randomized multi-centre trial of occluded artery angioplasty after acute myocardial infarction. Eur Heart J 25 (2004) 2187-2194
25. Yousef Z.R., Redwood S.R., Bucknall C.A., Sulke A.N., and Marber M.S. Late intervention after anterior myocardial infarction: effects on left ventricular size, function, quality of life, and exercise tolerance: results of the Open Artery Trial (TOAT Study). J Am Coll Cardiol 40 (2002) 869-876
26. Dzavik V., Beanlands D.S., Davies R.F., Leddy D., Marquis J.F., Teo K.K., Ruddy T.D., Burton J.R., and Humen D.P. Effects of late percutaneous transluminal coronary angioplasty of an occluded infarct-related coronary artery on left ventricular function in patients with a recent (< 6 weeks) Q-wave acute myocardial infarction (Total Occlusion Post-Myocardial Infarction Intervention Study [TOMIIS]-a pilot study). Am J Cardiol 73 (1994) 856-861